Patent intelligence Β· IL
IL 300192
Manufacturing of dimeric contrast agents
Manufacturing of dimeric contrast agents
Patent details β IL 300192
- Jurisdiction
- IL
- Status
- granted
- Grant date
- Mar 1, 2023
- Expiration
- Feb 24, 2043
- Applicant
- BRACCO IMAGING SPA [IT]
- CPC classes
- A61K/49108
Quick answer
IL 300192 (Manufacturing of dimeric contrast agents) is held by BRACCO IMAGING SPA [IT]. Status: granted. Granted Mar 1, 2023. Expires Feb 24, 2043 (17 years remaining) β relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BRACCO IMAGING SPA [IT]
- Grant date
- Expiration
- Claims
- β
- CPC classes
- A61K/49108
More from BRACCO IMAGING SPA [IT]
Related pharmaceutical patents in our USPTO index.
-
CN 119365549
Fluorescent probe targeting CA-IX
granted -
CN 119343336
1, 4-bis-(2-hydroxy-benzyl)-1, 4, 7-triazacyclononane derivatives and similar compounds as ligands in iron (iii) complexes for use as MRI contrast agents
granted -
CN 119325492
Fluorescent probe targeting CA-IX
granted -
CN 118401500
Process for preparing mixtures of dimeric macrocyclic intermediates comprising gadolinium complexes
granted -
US 2024131199
PH RESPONSIVE CYANINE DYES AND CONJUGATES THEREOF
granted -
KR 20240034693
μ΄λ체 μ‘°μμ μ μ μ‘°
granted -
US 2023312523
NEAR-INFRARED CYANINE DYES AND CONJUGATES THEREOF
granted -
KR 20230116805
κ°λν 리λ μ μ‘°λ₯Ό μν μ μ‘° λ°©λ²
granted
Related coverage
Frequently asked questions
What is US patent 300192?
IL 300192 (Manufacturing of dimeric contrast agents) is held by BRACCO IMAGING SPA [IT]. Status: granted. Granted Mar 1, 2023. Expires Feb 24, 2043 (17 years remaining) β relevant for patent-cliff and LOE planning.
Who owns IL 300192?
BRACCO IMAGING SPA [IT] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does IL 300192 expire?
Our index shows an expiration date of Feb 24, 2043 (17 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.